Michael D. Fabrizio MD FACS
Minimally Invasive Surgery, Kidney Transplantation
Professor of Urology, Eastern Virginia Medical School Urology of Virginia, PLLC
Join to View Full Profile
3800 Reservoir Rd NWWashington, DC 20007
Phone+1 202-444-4922
Fax+1 877-625-1478
Dr. Fabrizio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Minimally Invasive Urologic Surgery, 1998 - 1999
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Urology, 1994 - 1998- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Surgery, 1992 - 1994
Virginia Commonwealth University School of MedicineClass of 1992
Certifications & Licensure
DC State Medical License 2025 - 2028
VA State Medical License 1999 - 2028
NC State Medical License 1999 - 2027
MD State Medical License 1998 - 2026
PA State Medical License 1993 - 2000
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 13 citationsA Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer.Rana R. McKay, Jason Hafron, Christine Ferro, Helen M. Wilfehrt, Kate Fitch
Advances in Therapy. 2020-10-07 - 68 citations17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W. Lin, Yingye Zheng, Jesse K. McKenney, Marshall D. Brown, Ruixiao Lu
Journal of Clinical Oncology. 2020-03-04 - 30 citationsPerformance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS).Lisa F. Newcomb, Yingye Zheng, Anna Faino, Daniella Bianchi-Frias, Matthew R. Cooperberg
Prostate Cancer and Prostatic Diseases. 2019-01-21
Press Mentions
Genomic Profiling: Germline and Somatic Testing - What You Must Know Today - Emmanuel AntonarakisDecember 16th, 2021
Protected: Helping A Loved One with Advanced Prostate CancerMarch 8th, 2019
Hormone-Sensitive Metastatic Prostate CancerMarch 14th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
